[go: up one dir, main page]

WO2008010042A3 - Improved process for the preparation of cefepime intermediate - Google Patents

Improved process for the preparation of cefepime intermediate Download PDF

Info

Publication number
WO2008010042A3
WO2008010042A3 PCT/IB2007/001897 IB2007001897W WO2008010042A3 WO 2008010042 A3 WO2008010042 A3 WO 2008010042A3 IB 2007001897 W IB2007001897 W IB 2007001897W WO 2008010042 A3 WO2008010042 A3 WO 2008010042A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
cefepime
improved process
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/001897
Other languages
French (fr)
Other versions
WO2008010042A2 (en
Inventor
Sureshkumar Kanagaraj
Mohan Singaravel
Narayanan Arunkumar Lakshmi
Palanisamy Senth Udayampalayam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orchid Pharma Ltd
Original Assignee
Orchid Chemicals and Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orchid Chemicals and Pharmaceuticals Ltd filed Critical Orchid Chemicals and Pharmaceuticals Ltd
Publication of WO2008010042A2 publication Critical patent/WO2008010042A2/en
Publication of WO2008010042A3 publication Critical patent/WO2008010042A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/187-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a process for the preparation of the compound of formula (I) wherein X represents iodo or chloro. The compound of formula (I) is an important intermediate in the preparation of Cefepime or its pharmaceutically acceptable salts.
PCT/IB2007/001897 2006-07-18 2007-07-09 Improved process for the preparation of cefepime intermediate Ceased WO2008010042A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1246/CHE/2006 2006-07-18
IN1246CH2006 2006-07-18

Publications (2)

Publication Number Publication Date
WO2008010042A2 WO2008010042A2 (en) 2008-01-24
WO2008010042A3 true WO2008010042A3 (en) 2008-06-12

Family

ID=38957140

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/001897 Ceased WO2008010042A2 (en) 2006-07-18 2007-07-09 Improved process for the preparation of cefepime intermediate

Country Status (1)

Country Link
WO (1) WO2008010042A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10568328B2 (en) 2013-03-15 2020-02-25 Monsanto Technology Llc Methods and compositions for weed control

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594131A (en) * 1992-07-24 1997-01-14 Bristol-Myers Squibb Company Process for preparing cephalosporin intermediates
WO2006008749A1 (en) * 2004-07-16 2006-01-26 Hetero Drugs Limited Process for preparing pure cephalosporine intermediates
WO2006075244A2 (en) * 2005-01-17 2006-07-20 Orchid Chemicals & Pharmaceuticals Ltd Improved process for the preparation of cephalosporin antibiotic intermediate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594131A (en) * 1992-07-24 1997-01-14 Bristol-Myers Squibb Company Process for preparing cephalosporin intermediates
WO2006008749A1 (en) * 2004-07-16 2006-01-26 Hetero Drugs Limited Process for preparing pure cephalosporine intermediates
WO2006075244A2 (en) * 2005-01-17 2006-07-20 Orchid Chemicals & Pharmaceuticals Ltd Improved process for the preparation of cephalosporin antibiotic intermediate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WALKER D.G. ET AL.: "Use of bistrimethylsilylated intermediates in the preparation of semisynthetic 7-amino-3-substituted cephems. Expedient syntheses of a new 3-[(1-methyl-1-pyrrolidinio)methyl]cephalosporin", J. ORG. CHEM., vol. 53, no. 5, 1988, pages 983 - 991 *

Also Published As

Publication number Publication date
WO2008010042A2 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
WO2008076046A8 (en) Novel 2-amino-5, 5-diaryl-imidazol-4-ones
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
WO2008083248A3 (en) Cyclopamine analogs
WO2008022286A3 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
MX2009012168A (en) Pyrrolopyridine derivatives and their use as bace inhibitors.
MY147390A (en) Substituted isoindoles as bace inhibitors and their use
TW200728307A (en) Novel spirochromanone derivatives
WO2007103839A3 (en) Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
WO2008013838A3 (en) Pyridizinone derivatives
WO2006053255A3 (en) Novel betulin derivatives, preparation thereof and use thereof
WO2007058583A3 (en) Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies
UA94833C2 (en) Substituted bicyclolactams
WO2008044243A3 (en) Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof
WO2007061360A3 (en) Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides
WO2008155615A3 (en) An improved process for the preparation of cephalosporin antibiotic
WO2007031933A3 (en) Stable pharmaceutical composition comprising a pyrimidine-sulfamide
WO2008058118A3 (en) Preparation of montelukast and its salts
WO2010097229A3 (en) Amorphous salt of a macrocyclic inhibitor of hcv
WO2010031832A3 (en) Synergistic combinations of a macrocyclic inhibitor of hcv and a thiophene-2-carboxylic acid derivative
WO2007126900A3 (en) Antifungal agents
WO2007014054A3 (en) Benzenesulfonamide inhibitor of ccr2 chemokine receptor
WO2008001201A3 (en) Pharmaceutical compositions of clopidogrel
WO2006113509A3 (en) Quinobenzoxazine analogs and methods of using thereof
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07804576

Country of ref document: EP

Kind code of ref document: A2